Abstract
Microparticles (MPs) are vesicles derived from the plasma membrane of different cells, are considered a source of circulating autoantigens, and can form immune complexes (MPs-ICs). The number of MPs and MPs-ICs increases in patients with systemic lupus erythematosus (SLE). MPs activate myeloid cells by inducing IL-6 and TNF-α in both SLE and other diseases. Therefore, we propose that the recognition of MPs-ICs by monocytes rather that MPs may define their phenotype and contribute to the inflammatory process in patients with SLE. Thus, the aims of this study were to evaluate the association among circulating MPs-ICs from different cell sources, alterations observed in monocyte subsets, and disease activity in patients with SLE and to establish whether monocytes bind and respond to MPs-ICs in vitro. Circulating MPs and monocyte subsets were characterized in 60 patients with SLE and 60 healthy controls (HCs) using multiparametric flow cytometry. Patients had higher MP counts and frequencies of MPs-CD41a + (platelet-derived) compared with HCs, regardless of disease activity. MPs from patients with SLE were C1q + and formed ICs with IgM and IgG. MPs-IgG + were positively correlated with active SLE (aSLE), whereas MPs-IgM + were negatively correlated. Most of the circulating total ICs-IgG + were located on MPs. The proportion and number of non-classical monocytes were significantly decreased in patients with SLE compared with HCs and in patients with aSLE compared with patients with the inactive disease. Non-classical monocytes obtained from patients with SLE exhibited increased levels of CD64 associated with MPs-IgG +, MPs-C1q +, total circulating ICs-IgG +, and disease activity. The direct effects of MPs and MPs-IgG + on monocytes were evaluated in cell culture. Monocytes from both HCs and patients bound to and internalized MPs and MPs-IgG + independent of CD64. These vesicles derived from platelets (PMPs), mainly PMPs-IgG +, activated monocytes in vitro and increased the expression of CD69, CD64, and pro-inflammatory cytokines such as IL-1β, TNF-α, and IFN-α. Therefore, MPs are one of the most representative sources of the total amount of circulating ICs-IgG + in patients with SLE. MPs-IgG + are associated with SLE activity, and PMPs-IgG + stimulate monocytes, changing their phenotype and promoting pro-inflammatory responses related to disease activity.
Highlights
Circulating autoantibodies against different nuclear components are one of the main serological hallmarks of systemic lupus erythematosus (SLE)
We focused our study on these extracellular vesicles, which display phenotypic characteristics that correspond to MPs by flow cytometry and will be called MPs hereafter
The circulating MP count was significantly higher in patients with inactive SLE (iSLE) (p < 0.01) and patients with active SLE (aSLE) (p < 0.001) compared with healthy controls (HCs) (Figures 1A,B) and significantly higher in total patients with SLE compared with patients with other systemic autoimmune diseases (SADs), such as rheumatoid arthritis (RA) (Figure S2A in Supplementary Material)
Summary
Circulating autoantibodies against different nuclear components are one of the main serological hallmarks of systemic lupus erythematosus (SLE). These autoantibodies can form immune complexes (ICs) in the circulation, which are deposited at the intravascular level, inducing inflammatory processes and tissue damage [1]. Different sources of autoantigens have been implicated in the formation of ICs in patients with SLE, including apoptotic bodies [2] that contain autoantigens such as DNA and modified histones [3], and, more recently, microparticles (MPs) [4]. MPs are vesicles derived from plasma membranes of activated and apoptotic cells (ACs). It has been observed that endothelial-derived MPs induced plasmacytoid dendritic cell maturation, in addition to upregulation of costimulatory molecules and inflammatory cytokines secretion (IL-6 and IL-8) [12]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.